Key result
A cardioinhibitory response during head-up tilt testing was associated with a significantly higher rate of syncope recurrence compared to a vasodepressor response (56.5% vs 27.7%).
Why the study?
Does cardioinhibitory response during head-up tilt test predict worse quality of life and higher syncope recurrence compared to vasodepressor response in patients with recurrent reflex syncope?
Does cardioinhibitory response during head-up tilt test predict worse quality of life and higher syncope recurrence compared to vasodepressor response in patients with recurrent reflex syncope?
Answers are grounded in this paper and cite their sources.
This editorial highlights that while a cardioinhibitory response during tilt testing is associated with higher syncope recurrence, it does not necessarily correlate with worse quality of life, though significant age differences between response types may confound these findings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2024) conducted an editorial in Reflex syncope (n=82). Cardioinhibitory (CI) response during head-up tilt test vs. Vasodepressor (VD) response was evaluated on Syncope recurrence. A cardioinhibitory response during head-up tilt testing was associated with a significantly higher rate of syncope recurrence compared to a vasodepressor response (56.5% vs 27.7%).
Synapse has enriched 10 related papers. Consider them for comparative context: